Human-AI Collaboration for Decision Making

Overseen By Jeremy M Wolfe, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Brigham and Women's Hospital

Disqualifiers: Color blindness, Vision worse than 20/25

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

15 Participants Needed

Trial Summary

What is the purpose of this trial?

The study is one part of a "bundle" of experiments that constitute Project Three of a National Eye Institute grant. Project Three includes a series of experiments that investigate how changing the input from a simulated AI can affect the decisions made by human observers in a two-alternative forced choice task (like the decision to recall a woman for further examination in mammography). HAICT 7, the experiment described here, investigates how changing prevalence affects human performance when AI is used as a Second Reader.

Research Team

Jeremy M Wolfe, PhD

Principal Investigator

Brigham and Women's Hospital

Eligibility Criteria

This trial is open to everyone who can enroll online. However, participants must pass the Ishihara color vision test and have at least 20/25 vision with correction if needed.

Inclusion Criteria

- All welcome to enroll on line

Exclusion Criteria

My vision is at least 20/25 with glasses or contacts.

Must pass the Ishihara color vision screening test

Treatment Details

Interventions

• Simulated Second Reader AI
• Target Prevalence

Trial Overview The study tests how simulated AI as a Second Reader affects human decision-making in tasks like mammography screening when the frequency of cases (prevalence) changes.

Participant Groups

Group I: Experiment Experimental Treatment 2 Interventions

All participants are tested in all conditions of this experiment.

Who Is Running the Clinical Trial?

Brigham and Women's Hospital

Lead Sponsor

Trials

1,694

Recruited

14,790,000+